Dympna Leonard is a Research Fellow at James Cook University (JCU), specializing in public health and nutrition, with a focus on Indigenous populations in Far North Queensland. She holds a PhD in Nutrition from JCU (2019), examining anaemia among Aboriginal and Torres Strait Islander mothers and children. Her research addresses health disparities in remote communities, emphasizing maternal and child health, anaemia prevention, and nutritional interventions. Her work spans epidemiological studies, policy analysis, and community-based interventions. Key areas include anaemia in infants and children, breastfeeding practices in gestational diabetes contexts, and the effectiveness of incentive programs to improve dietary choices. She collaborates with multidisciplinary teams and government agencies to design culturally appropriate health strategies. Leonard’s publications highlight trends in public health nutrition over decades, linking data silos to inform policy, and evaluating long-term health outcomes in Indigenous populations. Her research bridges clinical findings with actionable public health measures, aiming to reduce health inequalities in remote regions. No scientific awards are explicitly noted in the provided texts. However, her extensive peer-reviewed output demonstrates sustained academic contribution. She has advised on multiple studies but no formal advisee names are listed.
Professor Peter Nixon holds the position of Professor of Biochemistry in the Department of Life Sciences at Imperial College London's Faculty of Natural Sciences. His research focuses on solar energy conversion mechanisms in chloroplasts and cyanobacteria, including enhancing photosynthetic light reactions, photosystem II assembly/repair, and synthetic biology applications in agriculture and sustainability. Education: BA (Hons) Biochemistry from the University of Cambridge, followed by a PhD at Imperial College London. He also served as a Visiting Professor at Nanyang Technological University's School of Biological Sciences from 2016 to 2020. Key research interests include thiamine deficiency pathogenesis, folate bioavailability, and enzyme catalysis mechanisms. His work spans structural biology, synthetic biology, and food science applications. Recent publications highlight his long-standing contributions to understanding ethanol-induced neurological damage, transketolase biochemistry, and folate-milk protein interactions. He collaborates with multiple centers including the Centre for Solar Biotechnology, Bezos Centre for Sustainable Protein, and Molecular Plant and Microbial Systems.
Sandra Schick is a Group Leader at the Institute of Molecular Biology (IMB) in Mainz since 2020 and a Junior Faculty Member at the Max Planck Graduate Center (MPGC) since 2021. Her research focuses on ATP-dependent chromatin remodeling complexes, specifically BAF, and their critical roles in cancer pathogenesis and developmental disorders through regulation of DNA accessibility. Her primary research areas include: Chromatin remodeling mechanisms and epigenetic regulation Structure-function relationships of polymorphic BAF complexes Molecular basis of BAF subunit mutations in human diseases Integration of chromatin dynamics with DNA repair and transcriptional control Analysis of her publication record reveals a consistent trajectory in dissecting BAF complex functionality using multi-omics approaches, with emphasis on synthetic lethality networks in cancer and developmental disease contexts. Her work demonstrates how BAF perturbations immediately alter chromatin architecture, providing mechanistic insights for therapeutic targeting. Dr. Schick leads an active research group at IMB that employs CRISPR/Cas9, targeted protein degradation, single-cell genomics, and advanced imaging to investigate chromatin regulation across model systems. She actively recruits experimental and computational scientists to advance understanding of chromatin-related disease mechanisms and resilience pathways.
Alison Ward is an Associate Professor in the Department of Animal and Poultry Science at the University of Saskatchewan, Canada. Her research focuses on nutritional epigenetics, developmental programming, and molecular genetics in livestock, particularly examining how maternal nutrition affects fetal development and long-term health outcomes in beef cattle. She integrates multi-omics approaches, including transcriptomics and metabolomics, to study nutrient-gene interactions and improve precision agriculture practices. PhD (Animal Science), University of Saskatchewan MSc (Animal Science), University of Saskatchewan BSc (Animal Science), University of Saskatchewan Ward’s work bridges molecular biology, physiology, and genomics to address how maternal micronutrient and one-carbon metabolite supplementation during critical gestational periods alter fetal organ development, placental function, and epigenetic gene regulation. Her recent publications emphasize fetal liver programming, mitochondrial function, and transgenerational effects of maternal nutrition, with a strong focus on sustainable livestock production. Her research has been supported by grants from the USDA National Institute of Food and Agriculture, North Dakota Beef Commission, and other agricultural research bodies. She teaches ANSC 313 – Animal Breeding and Genetics, and has received teaching excellence awards from the University of Saskatchewan Students Union. 2024 Open Resources Initiative Award USSU Teaching Excellence Award
Elisabeth Qvigstad is an Associate Professor at the Department of Endocrinology, Obesity and Preventive Medicine within the Faculty of Medicine , University of Oslo . With a clinical and research focus on diabetes and metabolism, she has held roles including Senior Consultant (2013–present) and Head of Research and Development (2018–present) at Oslo University Hospital. Education: Cand. med. (1993), dr. med. (2003) from NTNU Leadership: Diabeteslaboratoriet på Aker , STORK project , EPIPREG cohort Her research spans gestational diabetes , insulin resistance , and epigenetic/genetic mechanisms linking maternal metabolism to fetal outcomes. She explores how factors like ethnicity, BMI, and physical activity influence diabetes risk during and after pregnancy, with collaborations across Norway and internationally (e.g., Lund University, GenDIP consortium). Recent studies include epigenetic signatures in maternal blood, genetic determinants of birth weight, and DNA methylation risk scores for gestational diabetes. Her work addresses diagnostic criteria, biomarker discovery, and long-term health implications for mothers and children. She leads advanced diagnostic testing at the Diabetes Laboratory and contributes to clinical trials (e.g., phase 2–4 drug studies). Teaching roles include lectures in diabetes and endocrinology for medical students and leadership in the Scandinavian Endocrinology Course (2015).
Dr. David Sychantha is an Assistant Professor at the University of Waterloo, leading the Sychantha Lab focused on bacterial cell wall homeostasis and antibiotic resistance mechanisms. His research integrates structural biology, enzymology, and chemical biology to elucidate how pathogenic bacteria modify cell surfaces to evade immune systems and resist antibiotics. Key interests include autolysin regulation, metallo-β-lactamase inhibition, and peptidoglycan biosynthesis. Education: PhD in Molecular & Cellular Biology (2018), University of Guelph MSc in Molecular & Cellular Biology (2013), University of Guelph BSc in Microbiology (2011), University of Guelph CIHR Fellow (2020-2023), McMaster University Research Focus: The lab investigates biochemical pathways governing bacterial cell wall remodeling, with emphasis on autolysins and metallo-β-lactamases. Current projects target: Structural and functional analysis of enzymes involved in cell wall homeostasis Mechanisms of antibiotic resistance in carbapenem-resistant pathogens Design of novel inhibitors targeting virulence factors Awards: CIHR Fellowship Award (2020-2023) Michael G. DeGroote Fellowship Award (2018-2019) Lab & Collaborations: The Sychantha Lab actively collaborates on structural enzymology projects and currently accepts graduate student applications via the University of Waterloo admissions portal. Research outputs include high-impact studies on antibiotic adjuvants, enzyme inhibition mechanisms, and bacterial pathogenesis strategies.
Prof. Dr. Jan Philipp Schuchardt is a Professor at the Department of Nutritional Physiology and Human Nutrition within the Institute of Food and One Health at Leibniz University Hannover's Faculty of Natural Sciences. His office is located at Am Kleinen Felde 30, 30167 Hannover (Building 2705, Room 238/239). He holds multiple administrative positions including Accreditation Officer for Food Science, BAFÖG Officer for Food Research and Development, Safety Officer for the Institute of Food Science and Human Nutrition, and Department Student Advisor for Food Science. Dr. Schuchardt's research primarily focuses on omega-3 fatty acids , nutritional physiology , and human nutrition . His work investigates the bioavailability of EPA and DHA, the relationship between omega-3 status and metabolic health, cognitive function, and inflammation. He has conducted extensive research on the Omega-3 Index across different populations including German women, elderly subjects, and Palestinian university students. His studies often examine how dietary interventions, particularly with marine oils like Calanus oil, fish oil, and krill oil, affect physiological markers related to glucose homeostasis, inflammation, and cognitive health. His publication record demonstrates a strong focus on nutritional epidemiology, with numerous studies examining population-level patterns of nutrient status. Recent work includes the 'Omega-3 world map: 2024 update' which provides a global perspective on omega-3 status across different countries. His research frequently employs advanced methodologies including machine learning techniques to identify patterns between nutrient intake and health outcomes. Dr. Schuchardt actively supervises doctoral students, bachelor's and master's theses as indicated on his institutional profile. His collaborative work spans international boundaries with research conducted in Germany, Palestine, and through analysis of large datasets like the UK Biobank.
E. Albert Reece, MD, PhD, MBA, is a Professor at the University of Maryland School of Medicine in the Department of Obstetrics, Gynecology and Reproductive Sciences. He serves as the CARTI Endowed Professor and Director of the Center for Advanced Research Training and Innovation (CARTI), and is a Senior Scientist at the Center for Birth Defects Research. Dr. Reece is a member of the National Academy of Medicine and previously served as Executive Vice President for Medical Affairs and Dean of the School of Medicine. His educational background includes: Bachelor of Science (Magna Cum Laude) from Long Island University MD from New York University School of Medicine PhD in Biochemistry from the University of the West Indies MBA from Temple University Residency in Obstetrics and Gynecology at Columbia University Medical Center Postdoctoral Fellowship in Maternal-Fetal Medicine at Yale University School of Medicine Dr. Reece's research focuses on the molecular mechanisms of diabetes-induced birth defects , particularly examining cytoarchitectural changes at the cellular level and biochemical alterations including membrane lipid depletion and oxidative stress. His laboratory employs rat and mouse models to investigate apoptotic pathways, JNK signaling, and protein kinase C isoforms in diabetic embryopathy, with emphasis on developing preventive interventions through vitamin and lipid therapies. His work bridges basic science with clinical applications in prenatal diagnosis and fetal therapy. Analysis of his recent publications reveals a consistent trajectory toward molecular mechanistic understanding of diabetic embryopathy, with increasing focus on oxidative stress signaling, specific apoptotic pathways, and genetic factors. His research demonstrates the progression from clinical observations of birth defect patterns to detailed cellular and molecular investigations, culminating in targeted therapeutic strategies. The interdisciplinary nature spans obstetrics, biochemistry, developmental biology, and molecular pharmacology. Scientific recognition includes: Distinguished Leadership Award (2009) Berson Medical Alumni Achievement Award in Health Sciences (2010) Distinguished Service Award from Loma Linda University (2010) Election to the National Academy of Medicine Dr. Reece has directed NIH-funded multi-million dollar research programs and served on influential committees including the FDA, NIH, Institute of Medicine, and March of Dimes Scientific Advisory Committee on Prematurity. His leadership extended to chairing the Association of American Medical Colleges Council of Deans and developing the ANGELS telemedicine system for rural obstetrical care. He has mentored numerous faculty and established performance-based incentive models for academic medicine. He directs the Center for Advanced Research Training and Innovation (CARTI), fostering interdisciplinary research in maternal-fetal health, and co-founded embryofetoscopy techniques for early prenatal diagnosis and potential fetal therapy. His laboratory group maintains active investigations into diabetes-induced embryopathy mechanisms while translating findings into clinical practice.
Brian J. Altman, Ph.D. is an Associate Professor in the Department of Biomedical Genetics at the University of Rochester Medical Center's School of Medicine and Dentistry. His research focuses on the intersection of circadian biology, cancer metabolism, and oncogenic signaling, particularly the role of the MYC oncogene in disrupting circadian rhythms in cancer cells. Dr. Altman received his PhD in Molecular Cancer Biology from Duke University in 2011 and his BA in Biology from the University of Pennsylvania in 2005. He leads the Altman Lab, which investigates how circadian rhythms influence cancer development and progression. His research interests include: The role of circadian rhythm in cancer cell biology and metabolism How the MYC oncogene disrupts circadian metabolic oscillations Molecular clock regulation in cancer cells Metabolic control of circadian rhythms in tumor microenvironments Therapeutic implications of circadian disruption in cancer Analysis of Dr. Altman's recent publications reveals a strong focus on the intersection of circadian biology and cancer metabolism. His work demonstrates how oncogenes like MYC disrupt circadian rhythms in cancer cells, leading to altered metabolic oscillations that may provide cancer cells with a growth advantage. His research spans multiple cancer types including lung cancer, colorectal cancer, and thyroid cancer, with particular emphasis on how circadian disruption affects tumor immune microenvironments and metabolic pathways. Dr. Altman has published extensively in high-impact journals including Nature Immunology, Cell Metabolism, PLoS Genetics, and Nature Communications. His research has significantly advanced understanding of the connections between circadian rhythms and cancer biology. As a mentor, Dr. Altman oversees several graduate students and postdoctoral scholars in his lab, guiding research on topics such as: Understanding the role of REV-ERB proteins in MYC-driven circadian disruption Modulation of the molecular clock by metabolic stress Connections between circadian rhythms and metabolic stress in macrophages and cancer cells His lab is currently working on several major projects including: Tumor suppression by the molecular clock MYC disruption of the circadian metabolic cycle Metabolic control of the molecular clock MYC and the clock in non-small cell lung cancer Endogenous MYC and the molecular clock in cancer
Cesare D'Amico is a Part-Time Lecturer at the University of Palermo within the School of Medicine and Surgery , specifically affiliated with the Department of Biomedicine, Neuroscience and Advanced Diagnostics . His research spans pharmacological and neurobiological domains, focusing on neuroplasticity and its modulation by cannabinoids and alcohol exposure. Email: cesare.damico@unipa.it Research Focus His work examines the impact of prenatal Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) on hippocampal neuroplasticity, spatial memory, and mitochondrial function in adolescent rat models. Additional studies explore proteomic insights into multiple sclerosis, synthetic pyrrolomycins for cancer treatment, and neuroendocrine consequences of alcohol abuse. Publication Trends Recent publications highlight his expertise in neuropharmacology , developmental neuroscience , and molecular oncology , with a strong emphasis on Cannabinoid receptor signaling , proteomic profiling , and microwave-assisted drug synthesis .
Anne Williams is an Adjunct Assistant Professor in the Hubert Department of Global Health at Emory University. She holds a PhD in Nutritional Biology from the University of California, Davis (2015), an MPH in Public Health from UC Davis (2010), and a BS in Aquatic and Fishery Science from the University of Washington (2003). Her research focuses on optimizing nutritional assessment methodologies, particularly improving maternal nutrition and anemia reduction strategies. Key areas include evaluating biomarkers for iron deficiency, analyzing the impact of water/sanitation interventions on nutritional outcomes, and investigating the role of inflammation in micronutrient status assessment. She is a core contributor to the BRINDA project, a multinational initiative refining anemia diagnostic criteria and inflammation adjustment methods. Her work integrates population-based survey data to address global health challenges, with a focus on maternal and child health in low-resource settings. Recent studies explore trends in dietary patterns (e.g., alternative milk consumption shifts in the US), the double burden of malnutrition, and the interplay between climate and health. Her publications emphasize methodological advancements in nutritional epidemiology, including hemoglobin cutoff re-evaluation, vitamin A biomarkers, and the design of culturally appropriate nutrition interventions. Notable contributions include guidelines for adjusting micronutrient biomarkers for inflammation and analyses linking food security to diet quality among SNAP recipients. Her research has informed global health policy through evidence-based strategies, particularly in sub-Saharan Africa and South Asia. Collaborations span academic institutions, NGOs, and governmental agencies to advance scalable nutrition interventions.
A. Baierl is a researcher at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, working within the Division of Clinical Epidemiology and Aging Research. With numerous publications spanning from 2019 to 2025, Baierl contributes to international research consortia focused on colorectal cancer epidemiology and metabolism. Baierl's research primarily investigates the complex relationship between metabolic pathways and colorectal cancer outcomes. Their work demonstrates particular expertise in tryptophan-kynurenine metabolism , vitamin status (particularly B-vitamins and folate) , and plasma metabolite profiling in cancer patients. This research has important implications for understanding cancer prognosis, recurrence risk, and potential nutritional interventions. Their collaborative approach is evident through participation in multiple international cohort studies including the ColoCare Study, Colorectal Cancer Study of Austria (CORSA), and European Prospective Investigation into Cancer and Nutrition (EPIC). The publication record reveals a consistent focus on biomarker discovery and validation across multiple studies. Baierl's work frequently examines how circulating metabolites can predict cancer outcomes, with particular attention to stage-specific effects and differences between colon and rectal cancer subtypes. The research has been published in high-impact journals including International Journal of Cancer , American Journal of Clinical Nutrition , and Cancers . Baierl works within an extensive collaborative network focused on colorectal cancer research, contributing to large international consortia that pool data from multiple institutions across Europe. This collaborative approach enables sufficiently large sample sizes to investigate nuanced questions about cancer metabolism and outcomes.
Mae J Ciancio, Ph.D., is a Professor of Biomedical Sciences at Midwestern University, holding concurrent appointments in the College of Graduate Studies, Chicago College of Osteopathic Medicine, College of Dental Medicine-Illinois, and College of Health Sciences-Downers Grove. She serves as Program Coordinator for the Biomedical Sciences Program since 2018. Her academic credentials include a Ph.D. from Loyola University Chicago (1989), B.A. from Northwestern University (1981), and postdoctoral training at the University of Chicago Medical Center in gastroenterology. Research focuses on three primary areas: (1) anti-obesity mechanisms of heat shock protein 70 (HSP70), particularly in high-fat diet models; (2) pathogenesis of oral squamous cell carcinoma using chemically induced mouse models; and (3) HSP70's protective role against Chlamydia muridarum-induced inflammation. Notable recent work includes studies on microbiome dynamics in clinical environments and dietary impacts on cancer progression. Teaching responsibilities span courses like Research Design and Methodology , Microbiome in Health and Disease , and Seminar in Biomedical Sciences . Active grant funding includes an intramural grant investigating photobiomodulation therapy in oral cancer. Publications emphasize interdisciplinary approaches at the intersection of microbiology, physiology, and clinical science, with recent contributions in DENTAL MATERIALS , ORAL DISEASES , and PLOS ONE . Over 200 research articles demonstrate sustained productivity in translational biomedical research.
Vasco Bonifácio is an Assistant Professor at the Department of Bioengineering, Instituto Superior Técnico (IST), Lisbon, Portugal. He is affiliated with the Institute of Bioengineering and Biociences (INEB) and the Scientific Area of Biomaterials, Nanotechnology, and Regenerative Medicine. His research focuses on dendrimers, luminescent materials, green chemistry, mechanochemistry, and cancer theranostics. He teaches Biomolecular Engineering, Biomaterials Technology, and Integrative Biotechnology Projects. Bonifácio leads funded projects in cancer therapy, regenerative medicine, and drug delivery, including collaborations with Merck and AMGEN. He supervises PhD students in cancer metabolism, nanotherapeutics, and exosome engineering, and MSc students in protein stabilization. His scientific contributions include pioneering work on polyurea dendrimers for targeted drug delivery, mechanochemical synthesis of biometallic complexes, and sustainable molecularly imprinted polymers. He has developed novel dry powder formulations for pulmonary delivery and engineered exosomes for amyloid-beta clearance. Awards include the Outstanding Teaching Award (IST Pedagogical Council) and the Advanced Materials Scientist Medal (IAAM). Bonifácio's lab integrates nanomedicine, materials science, and sustainable chemistry. Key projects include tackling ovarian cancer chemoresistance via BSO nanodelivery and developing smart nanocarriers for targeted therapies. He also innovates in accessible science education for visually impaired users through tools like NavMol software.
Dr. Simon Harris is a researcher affiliated with Newcastle University , contributing to diverse fields including Molecular Biology , Genetics , Microbiology , and Biomedical Sciences . His work spans evolutionary biology, genomic dynamics, and clinical studies, as evidenced by his publications. Research Interests: Harris's research focuses on topics such as bacterial secretion systems, reductive evolution in parasites, DNA methylation mechanisms, and phylogenetic methodologies. His studies also extend to clinical applications like liver fibrosis biomarkers and immunological disorders. Publications from 2002–2025 reveal expertise in microbial genetics, evolutionary theory, and biomedical research. Key themes include Molecular Evolution , Genomic Diversity , and Translational Medicine .
